Patents Assigned to L.A.M. Pharmaceutical Corporation
  • Publication number: 20030175354
    Abstract: This invention relates to a stable, sterilized, purified composition having a polymer matrix and a therapeutically effective amount of a drug, wherein the drug can be used to prevent or treat drug-induced, alcohol-induced, biologically-induced, trauma-induced or pain-induced nausea, vomiting, dizziness and other adverse effects arising from but not limited to motion sickness, cancer therapy, and pregnancy. In particular, the polymer matrix may be conformable to topical application on animal skin.
    Type: Application
    Filed: March 18, 2003
    Publication date: September 18, 2003
    Applicant: L.A.M. Pharmaceutical Corporation
    Inventors: Alan Drizen, Gary M. Nath
  • Publication number: 20030138494
    Abstract: Topical gelled compositions comprising a drug which causes vasodilation, and optionally prostaglandin E1, dispersed within a polymer matrix, and, methods of treating sexual dysfunction, including both male and female sexual dysfunction, using said compositions.
    Type: Application
    Filed: February 4, 2003
    Publication date: July 24, 2003
    Applicant: L.A.M. PHARMACEUTICAL CORPORATION
    Inventors: Alan Drizen, Peter Rothbart, Gary M. Nath
  • Patent number: 6514536
    Abstract: Topical gelled compositions comprising a drug which causes vasodilation, and optionally prostaglandin E1, dispersed within a polymer matrix, and methods of treating sexual dysfunction, including both male and female sexual dysfunction, using said compositions.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: February 4, 2003
    Assignee: L.A.M. Pharmaceutical Corporation
    Inventors: Alan Drizen, Peter Rothbart, Gary M. Nath
  • Patent number: 6387407
    Abstract: Topical gelled compositions comprising an optional drug dispersed within a polymer matrix, methods of producing the same and treatments with the complex.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: May 14, 2002
    Assignee: L.A.M. Pharmaceutical Corporation
    Inventors: Alan Drizen, Peter Rothbart, Gary M. Nath
  • Patent number: 6346271
    Abstract: Topical gelled compositions comprising an optional drug dispersed within a polymer matrix, methods of producing the same and treatments with the complex.
    Type: Grant
    Filed: April 8, 1999
    Date of Patent: February 12, 2002
    Assignee: L. A. M. Pharmaceutical Corporation
    Inventors: Alan Drizen, Peter Rothbart, Gary M. Nath
  • Patent number: 6335035
    Abstract: Sustained release compositions comprising a drug dispersed within a polymer matrix, methods of producing the same and treatments with the complex.
    Type: Grant
    Filed: February 28, 2000
    Date of Patent: January 1, 2002
    Assignee: L.A.M. Pharmaceutical Corporation
    Inventors: Alan Drizen, Peter Rothbart, Gary M. Nath
  • Patent number: 6335034
    Abstract: Topical gelled compositions comprising an optional drug dispersed within a polymer matrix, methods of producing the same and treatments with the complex.
    Type: Grant
    Filed: March 29, 2000
    Date of Patent: January 1, 2002
    Assignee: L.A.M. Pharmaceutical Corporation
    Inventors: Alan Drizen, Peter Rothbart, Gary M. Nath
  • Patent number: 6251436
    Abstract: Topical gelled compositions comprising a drug which causes vasodilation, and optionally prostaglandin E1, dispersed within a polymer matrix, and methods of treating sexual dysfunction, including both male and female sexual dysfunction, using said compositions.
    Type: Grant
    Filed: September 8, 1998
    Date of Patent: June 26, 2001
    Assignee: L.A.M. Pharmaceutical Corporation
    Inventors: Alan Drizen, Peter Rothbart, Gary M. Nath